Christopher Nixon Cox - Jan 2, 2025 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
Director
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Stock symbol
ANRO
Transactions as of
Jan 2, 2025
Transactions value $
$79,998
Form type
4
Date filed
1/6/2025, 04:17 PM
Previous filing
Feb 7, 2024
Next filing
Mar 28, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANRO Stock Option (right to buy) Award $80K +25.2K $3.17 25.2K Jan 2, 2025 Common Stock 25.2K $4.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 6,309 shares underlying the option shall vest on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025, subject to the Reporting Person's continuous service through each such vesting date.
F2 This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $80,000.